| Bioactivity | FAK-IN-21 (compound 9) is a FAK inhibitor with the IC50 of 37.52 nM. FAK-IN-21 inhibits cell growth and the phosphorylation of FAK. FAK-IN-21 can be used for study of diffuse gastric cancer[1]. |
| CAS | 2919213-32-2 |
| Formula | C22H22F2N8O3S |
| Molar Mass | 516.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang HaiSheng, et al. Pyrrolopyrimidine or pyrrolopyridine derivative and medical use thereof. China, WO2023036252A1. 2023-03-16. |
FAK-IN-21
CAS: 2919213-32-2 F: C22H22F2N8O3S W: 516.52
FAK-IN-21 (compound 9) is a FAK inhibitor with the IC50 of 37.52 nM. FAK-IN-21 inhibits cell growth and the phosphorylat
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.